NCT03411135

Completed

Vitiligo Extent Score (VES) Score in Comparison to Vitiligo ...

Cairo University Source

Compare

Other study identifiers

Sponsor study identifier

Dermatology6

Study Type

observational

Actual enrollment (reported)

101

Locations

0 countries

Sites

N/A

Timeline

Study Start

April 2016

Actual (reported)

Primary Completion

September 2016

Actual (reported)

Study Completion

September 2016

Actual (reported)

Brief Summary

All patients with vitiligo attending dermatology outpatient clinic at Kasr Alainy Teaching Hospital will be enrolled in this study to compare VES and VASI scores and evaluate them as assessment methods

Registry Overview

Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.

Recruitment status: completed
Actual enrollment (reported): 101 participants
Study completion date: September 2016
Actual (reported)
Listed locations: 0 countries · 0 sites

Trial Relationships

Click on a node to explore related trials.

Some registry-reported names shown below are not yet linked in this graph.

Study Timeline

Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.

Study Start
April 2016
Actual (reported)
Primary Completion
September 2016
Actual (reported)
Study Completion
September 2016
Actual (reported)
First Submitted
January 19, 2018
Actual (reported)
First Posted
January 26, 2018
Actual (reported)

Last Updated: January 26, 2018
Status Verified: January 2018
Last Update Submitted: January 24, 2018

Conditions

Vitiligo

Outcome Measures

Primary Outcomes (1)

The evaluation of the use of vitiligo extent score (VES) as a scoring system for vitiligo
6 months

Interventions

VES and VASI scores as assessment methods for vitiligoOther

compare VES and VASI scores as assessment methods for vitiligo

Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.

Eligibility Criteria

Age18 Years+

Sexall

Healthy VolunteersNo

Age GroupsAdult (18-64), Older Adult (65+)

Sampling MethodNon-Probability Sample

Study Population

Vitiligo patients presenting to dermatology outpatient clinic at Kasr Alainy Teaching Hospital.

You may qualify if:

Age \> 18.

Sponsors & Collaborators

Cairo University
Otherlead

MeSH Terms

Conditions

Vitiligo

Interventions

Polyvinyl Chloride

Condition Hierarchy (Ancestors)

HypopigmentationPigmentation DisordersSkin DiseasesSkin and Connective Tissue Diseases

Intervention Hierarchy (Ancestors)

PolyvinylsVinyl CompoundsAlkenesHydrocarbons, AcyclicHydrocarbonsOrganic ChemicalsPlastics

Enrollment

101 participants (actual enrollment reported by the registry).

Study Design

Study Type: observational
Observational Model: OTHER
Time Perspective: PROSPECTIVE
Sponsor Type: OTHER
Responsible Party: PRINCIPAL INVESTIGATOR
PI Title: principal investigator

Study Record Dates

First Submitted

January 19, 2018

First Posted

January 26, 2018

Study Start

April 2016

Actual (reported)

NCT03755830

Prostaglandin F2-alpha (PGF2α) in Vitiligo

Not ApplicableUnknown

NCT01459055

Long-term Follow-up in Patients Affected With Acrofacial Vitiligo

Unknown

NCT03013049

A Novel Surgical Method in the Treatment of Unstable Vitiligo

Not ApplicableUnknown

NCT05812079

Insulin Like Growth Factor-1 Against Oxidative Stress in Vitiligo

Unknown

NCT02281058

Open-label Pilot Study of Abatacept for the Treatment of Vitiligo

Phase 1Unknown

NCT02809976

Topical Ruxolitinib for the Treatment of Vitiligo

Phase 2Completed

Non-segmental vitiligo patients

You may not qualify if:

Age \< 18
Segmental vitiligo

Contact the study team to confirm eligibility.

Polymers

Macromolecular Substances

Elastomers

Biomedical and Dental Materials

Manufactured Materials

Technology, Industry, and Agriculture

Primary Completion

September 2016

Actual (reported)

Study Completion

September 2016

Actual (reported)

Last Updated

January 26, 2018

Record last verified: 2018-01

Source record

Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.

Source: ClinicalTrials.gov.

JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.

Registry identifier: NCT03411135
Data provider: ClinicalTrials.gov
Source updated: 2018-01-26
Normalization version: ctgov-legacy-1

Open registry record

Source retrieved: 2026-10-25 22:37:02 UTC

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

Study Start

Primary Completion

Study Completion

First Submitted

First Posted

Conditions

Outcome Measures

Primary Outcomes (1)

Interventions

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

MeSH Terms

Conditions

Interventions

Condition Hierarchy (Ancestors)

Intervention Hierarchy (Ancestors)

Enrollment

Study Design

Study Record Dates

You may not qualify if:

Source record